Total submissions: 15
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000118283 | SCV000312087 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Athena Diagnostics | RCV000713156 | SCV000843735 | benign | not provided | 2018-05-07 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002312499 | SCV000846158 | benign | Inborn genetic diseases | 2015-12-31 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV001509964 | SCV001716883 | benign | Early infantile epileptic encephalopathy with suppression bursts | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000713156 | SCV001870630 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001807067 | SCV002054581 | benign | Myoclonus, familial, 2 | 2021-07-15 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001807064 | SCV002054582 | benign | Cognitive impairment with or without cerebellar ataxia | 2021-07-15 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001807065 | SCV002054583 | benign | Developmental and epileptic encephalopathy, 13 | 2021-07-15 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001807066 | SCV002054586 | benign | Seizures, benign familial infantile, 5 | 2021-07-15 | criteria provided, single submitter | clinical testing | |
Unidad de Genómica Garrahan, |
RCV000118283 | SCV005087323 | benign | not specified | 2024-07-15 | criteria provided, single submitter | clinical testing | This variant is classified as Benign based on local population frequency. This variant was detected in 88% of patients studied in a panel designed for Epileptic and Developmental Encephalopathy and Progressive Myoclonus Epilepsy. Number of patients: 82. Only high quality variants are reported. |
Breakthrough Genomics, |
RCV000713156 | SCV005228880 | benign | not provided | criteria provided, single submitter | not provided | ||
Genetic Services Laboratory, |
RCV000118283 | SCV000152655 | likely benign | not specified | no assertion criteria provided | clinical testing | Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. | |
Diagnostic Laboratory, |
RCV000118283 | SCV001742214 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000118283 | SCV001955220 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000118283 | SCV001976039 | benign | not specified | no assertion criteria provided | clinical testing |